MusclePharm Sheds 75% Of Portfolio, Flexes After Spending Stretched It Thin
This article is powered by The Rose Sheet
Executive Summary
MusclePharm whittled its product line from 450 to 120 SKUs and is shifting its distribution focus in the US from specialty retail to Amazon and Costco. The firm also cut operating costs, spending $10m less in 2017 than in 2016.